🇺🇸 FDA
Pipeline program

Aflibercept

EVER STUDY

Approved small_molecule terminated

Quick answer

Aflibercept for Fibrovascular Pigment Epithelial Detachment is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Fibrovascular Pigment Epithelial Detachment
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials